Back to list BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States The Official State visit by the…
Back to list BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program Encouraging non-human primate (NHP) findings support the progression of IV-formulated BMD-001 ahead of formal clinical studies for Alzheimer's disease,…
Back to list BIORCHESTRA Expands Executive Leadership Team with the Appointment of David Oxley as Chief Business Officer CAMBRIDGE, Mass. and DAEJEON, South Korea, April 5, 2023 -- BIORCHESTRA, a biotherapeutics company focused on the treatment…